James F. Young, Ph.D.
Board Member
Novavax Inc (NVAX)Equibles does not estimate personal net worth.
Get an email with a short summary when Novavax Inc publishes a filing, an earnings call transcript or a press release.
Get NVAX alertsAbout James F. Young, Ph.D.
James F. Young, Ph.D. is recorded as Board Member at Novavax Inc (NVAX) since June 16, 2022. Novavax Inc reported in an 8-K filed June 21, 2022 that James F. Young, Ph.D. was appointed Class III nominees for director, effective June 16, 2022. Novavax Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Novavax Inc includes John C. Jacobs (CEO and Board Member), James P. Kelly (CFO), John J. Trizzino (CFO and COO) and 7 others.
“Stockholders elected the following Class III nominees for director, each to serve a three-year term expiring at the 2025 Annual Meeting of Stockholders:”
Affiliation history
-
Current
2022-06-16–present
Company network
Leadership on record at Novavax Inc
- John C. Jacobs CEO, Board Member
- James P. Kelly CFO
- John J. Trizzino CFO, COO
- John Trizzino CFO
- Mark Casey General Counsel
- Charles W. Newton Board Member
- David M. Mott Board Member
- David Mott Board Member
- Gregg H. Alton Board Member
- Gregg H. Alton, J.D. Board Member